Glaxosmithkline Consumer Healthcare Holdings (US) LLC DBA Haleon
Consumer health care company
Based in NJ
🤖
AI Overview
With $620K in lobbying spend across 9 quarterly filings, Glaxosmithkline Consumer Healthcare Holdings (US) LLC DBA Haleon is an active lobbying client. Their lobbying covers 6 issue areas. Active from 2022 to 2023.
$620K
Total Spend
2
Years Active
1
Firms Hired
6
Lobbyists Deployed
6
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $190K |
| 2023 | $430K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, MED, Health Issues, Budget/Appropriations, TOB and 1 more
- •Oral health; tobacco cessation; self-care; dietary supplements; FDA policy for over-the-counter products; pain management
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.